Shiloh
Editor, Senior Moderator
Source: https://www.paho.org/en/documents/s...ntry-outbreak-region-americas-31-january-2025
Situation Report: Mpox Multi-Country Outbreak - Region of the Americas - 31 January 2025
[TABLE="class: table table-hover table-striped"]
[TR="class: document-row"]
[TD="class: views-field views-field-field-image views-align-left views-field-field-documento-1 views-field-nothing"]
Download[/TD]
[TD="class: views-field views-field-body"]Between 2022 and 31 December 2024, a total of 118,777 confirmed cases of mpox have been reported globally, from 127 countries and territories.
The Region of the Americas (56.6%) contributes the largest proportion of cases, followed by the European (24.1%) and African Regions (13.4%).
In the Region of the Americas, a cumulative total of 67,220 confirmed cases of mpox, including 151 deaths were reported in 31 countries and territories between 2022 and 2024. The highest proportion of cases was recorded in 2022 (57,616 cases, 85.7%), followed by a downward trend in 2023 (4,056 cases, 6%) and a slight increase in 2024 (5,548 cases, 8.3%).
On 14 January 2025, the United States of America reported its second clade Ib mpox case—an imported infection in an individual with a history of travel to East Africa. The United States and Canada remain the only two countries in the Region to have reported cases of mpox clade Ib. No secondary case has been detected in the Region so far.
Access this report for more details.[/TD]
[/TR]
[/TABLE]
Situation Report: Mpox Multi-Country Outbreak - Region of the Americas - 31 January 2025
[TABLE="class: table table-hover table-striped"]
[TR="class: document-row"]
[TD="class: views-field views-field-field-image views-align-left views-field-field-documento-1 views-field-nothing"]
Download[/TD]
[TD="class: views-field views-field-body"]Between 2022 and 31 December 2024, a total of 118,777 confirmed cases of mpox have been reported globally, from 127 countries and territories.
The Region of the Americas (56.6%) contributes the largest proportion of cases, followed by the European (24.1%) and African Regions (13.4%).
In the Region of the Americas, a cumulative total of 67,220 confirmed cases of mpox, including 151 deaths were reported in 31 countries and territories between 2022 and 2024. The highest proportion of cases was recorded in 2022 (57,616 cases, 85.7%), followed by a downward trend in 2023 (4,056 cases, 6%) and a slight increase in 2024 (5,548 cases, 8.3%).
On 14 January 2025, the United States of America reported its second clade Ib mpox case—an imported infection in an individual with a history of travel to East Africa. The United States and Canada remain the only two countries in the Region to have reported cases of mpox clade Ib. No secondary case has been detected in the Region so far.
Access this report for more details.[/TD]
[/TR]
[/TABLE]